ReviewLife (Basel, Switzerland)2023

IMiD-Free Interval and IMiDs Sequence: Which Strategy Is Better Suited for Lenalidomide-Refractory Myeloma?

Kazuhito Suzuki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.